Le Lézard
Classified in: Health
Subjects: EXE, PSF

/R E P E A T -- Advisory - Alesse 21 and 28 birth control pill: Packages may contain broken or smaller-than-normal pills, which may reduce effectiveness in preventing pregnancy/



OTTAWA, Dec. 1, 2017 /CNW/ -

Issue
Health Canada is advising consumers and health care professionals that complaints have been received for packages of Alesse 21 (21 active pills) and Alesse 28 (21 active pills, 7 that contain no hormones). The blister packages for both contained an active (pink) pill that was roughly half the proper size. 

Alesse 21 and Alesse 28 are prescription drugs used to prevent pregnancy.

Who is affected

Affected products

What consumers should do

Additional information for pharmacists:

Background
Broken or smaller-than-normal birth control pills may deliver a smaller dose of the active drug ingredient, which could reduce its effectiveness in preventing pregnancy.

What Health Canada is doing
Health Canada is working with the company, Pfizer Canada, to determine the nature and scope of the issue. We will continue to monitor the situation and assess the need for further action. Health Canada will update consumers and health care professionals as appropriate.

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

20 jan 2018
Princeton Identity Inc., provider of the fastest, simplest and most secure biometric security system on the market, today announced the deployment of its Access500etm identity management kiosk module within the Dubai International Airport (DXB)....

20 jan 2018
Array BioPharma Inc. and Pierre Fabre today announced updated results from the 30 patient safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab,...

20 jan 2018
The 15th Guignolée du Dr Julien ended this week with a total of $1,744,000 raised in support of the Fondation du Dr Julien's three centres of expertise (CSPC Hochelaga-Maisonneuve, CSPC Côte-des-Neiges and Garage à musique). This amount represents...

20 jan 2018
Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluropyrimidine-, oxaliplatin- and...

20 jan 2018
Top 10 Jungle, a provider of slick digital content and online product reviews for the medical alert industry, explains to seniors and medical alert customers how a government shutdown can affect them. Top 10 Jungle recently released its 2018...

19 jan 2018
The food recall warning issued on January 12, 2018 has been updated to include additional product information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Imperial Caviar...




News published on 2 december 2017 at 07:00 and distributed by: